With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
There is a clear economic case for accelerating investment and progress toward improved global health security – the cost of preparedness and prevention is a fraction of the cost of response and recovery. The question is how to get the sizing, organization, and incentives of financing preparedness right at national and global levels, ensuring resources are in place to mount an effective, coordinated response when health emergencies occur.
Sustained and substantial funds are vital for global health security, but the landscape of financing for preparedness, prevention and response is fragmented and poorly governed. Multiple international programs, initiatives, and institutions have evolved in the aftermath of past pandemics, but many were small and inadequately funded; the COVID-19 pandemic has further exposed the ways in which global preparedness and response are under-resourced and under-prioritized. What financing commitments, structures, and mechanisms will emerge from the COVID-19 pandemic to ensure fit-for-purpose financing for global health security going forward?
CGD experts have been examining and working to improve financing for preparedness, prevention, and response since long before the COVID-19 pandemic, including work on financing for the response to Ebola and antimicrobial resistance, and the global health team continues to provide research, commentary, and analysis for actionable solutions and transformative ways forward.
While the misuse of antimicrobials in human health is a key factor accelerating the emergence of drug resistance, we should not overlook the role of agriculture. This paper makes the case for a global treaty to reduce antimicrobial use in livestock.
In an increasingly interconnected world, drug resistance does not stop at a patient’s bedside—it threatens global health. The conclusions of the Center for Global Development’s Drug Resistance Working Group make clear the need for urgent action to address this growing crisis.